Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

AIMTAIMT
6 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in AIMMUNE THERAPEUTICS INC

STIFEL FINANCIAL CORP previously held 0 shares of AIMT (AIMMUNE THERAPEUTICS INC), worth $0 as of 2020-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$488,000

Total Shares Change

-23,264

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%
0
2020-Q3
Decreased
9,651
-62.4%
$332,0000.0%
0
2020-Q2
Decreased
25,641
-14.1%
$428,0000.0%
0
2020-Q1
Decreased
29,863
-14.8%
$431,0000.0%
0
2019-Q4
Increased
35,057
+50.7%
$1.2M0.0%
35
2019-Q3
New
23,264
-
$488,0000.0%
33

Other major holders of AIMT: Pentwater Capital Management LP, VICTORY CAPITAL MANAGEMENT INC, ALLIANCEBERNSTEIN L.P., Magnetar Financial LLC, Fiera Capital Corp

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used